| 000 | 00731nam a22002057a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220906184638.0 | ||
| 008 | 140831b xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9290360682 | ||
| 110 |
_aCouncil for International Organizations of Medical Sciences (CIOMS) _92393 |
||
| 245 | _aBenefit-risk balance for marketed drugs: evaluating safety signals | ||
| 260 |
_aGeneva _bCouncil for International Organizations of Medical Sciences (CIOMS) _c1998 |
||
| 300 | _a160p. | ||
| 650 |
_aDrugs _9333 |
||
| 650 |
_aPharmaceutic Preparations _92394 |
||
| 650 |
_aPharmaceutical Products _92395 |
||
| 650 |
_aPreparations, Pharmaceutical _92396 |
||
| 856 |
_uhttp://nhrc.org.np/contact _yVisit NHRC Library |
||
| 942 |
_2NLM _cBK |
||
| 999 |
_c1977 _d1977 |
||